PKN3 (gene)

From Wikipedia, the free encyclopedia
Jump to: navigation, search
PKN3
Identifiers
Aliases PKN3, UTDP4-1, protein kinase N3
External IDs MGI: 2388285 HomoloGene: 50980 GeneCards: PKN3
Genetically Related Diseases
obesity[1]
RNA expression pattern
PBB GE PKN3 gnf1h00136 at fs.png

PBB GE PKN3 gnf1h00137 s at fs.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_013355
NM_001317926

NM_153805

RefSeq (protein)

NP_001304855
NP_037487

NP_722500.1
NP_722500

Location (UCSC) Chr 9: 128.7 – 128.72 Mb Chr 2: 30.08 – 30.09 Mb
PubMed search [2] [3]
Wikidata
View/Edit Human View/Edit Mouse

PKN3 is a protein kinase C-related molecule and thought to be an effector mediating malignant cell growth downstream of activated phosphoinositide 3-kinase (PI3K).[4] It is thought that chronic activation of the phosphoinositide 3-kinase (PI3K)/PTEN signal transduction pathway contributes to metastatic cell growth and that PKN3 may mediate that growth.1

PKN3 is required for invasive prostate cell growth as assessed by 3D cell culture assays and in an orthotopic mouse tumor model by inducible expression of short hairpin RNA (shRNA). PKN3 may represent a target for therapeutic intervention in cancers that lack tumor suppressor PTEN function or depend on chronic activation of PI3K.

Interactions[edit]

PKN3 (gene) has been shown to interact with ARHGAP26.[5]

References[edit]

  1. ^ "Diseases that are genetically associated with PKN3 view/edit references on wikidata". 
  2. ^ "Human PubMed Reference:". 
  3. ^ "Mouse PubMed Reference:". 
  4. ^ "Entrez Gene: PKN3 protein kinase N3". 
  5. ^ Shibata H, Oishi K, Yamagiwa A, Matsumoto M, Mukai H, Ono Y (July 2001). "PKNbeta interacts with the SH3 domains of Graf and a novel Graf related protein, Graf2, which are GTPase activating proteins for Rho family". Journal of Biochemistry. 130 (1): 23–31. doi:10.1093/oxfordjournals.jbchem.a002958. PMID 11432776. 

Further reading[edit]

  • Wissing J, Jänsch L, Nimtz M, Dieterich G, Hornberger R, Kéri G, Wehland J, Daub H (March 2007). "Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry". Molecular & Cellular Proteomics. 6 (3): 537–47. doi:10.1074/mcp.T600062-MCP200. PMID 17192257. 
  • Leenders F, Möpert K, Schmiedeknecht A, Santel A, Czauderna F, Aleku M, Penschuck S, Dames S, Sternberger M, Röhl T, Wellmann A, Arnold W, Giese K, Kaufmann J, Klippel A (August 2004). "PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase". The EMBO Journal. 23 (16): 3303–13. doi:10.1038/sj.emboj.7600345. PMC 514518Freely accessible. PMID 15282551. 
  • Shibata H, Oishi K, Yamagiwa A, Matsumoto M, Mukai H, Ono Y (July 2001). "PKNbeta interacts with the SH3 domains of Graf and a novel Graf related protein, Graf2, which are GTPase activating proteins for Rho family". Journal of Biochemistry. 130 (1): 23–31. doi:10.1093/oxfordjournals.jbchem.a002958. PMID 11432776. 
  • Oishi K, Takahashi M, Mukai H, Banno Y, Nakashima S, Kanaho Y, Nozawa Y, Ono Y (May 2001). "PKN regulates phospholipase D1 through direct interaction". The Journal of Biological Chemistry. 276 (21): 18096–101. doi:10.1074/jbc.M010646200. PMID 11259428. 
  • Oishi K, Mukai H, Shibata H, Takahashi M, Ona Y (August 1999). "Identification and characterization of PKNbeta, a novel isoform of protein kinase PKN: expression and arachidonic acid dependency are different from those of PKNalpha". Biochemical and Biophysical Research Communications. 261 (3): 808–14. doi:10.1006/bbrc.1999.1116. PMID 10441506.